Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06803745 · ClinicalTrials.gov registry record · NA
Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)
A NA study of Acute Leukemia and Acute Lymphoblastic Lymphoma, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT06803745: Recruiting NA study of Acute Leukemia and Acute Lymphoblastic Lymphoma, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
NCT06803745 is a NA study of Acute Leukemia and Acute Lymphoblastic Lymphoma that is actively recruiting participants, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 160 participants, below the 459-participant average among 37 other Acute Leukemia trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06803745, a NA study of Acute Leukemia and Acute Lymphoblastic Lymphoma, is actively recruiting participants, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized phase II trial of standard-of-care reduced-intensity conditioning (RIC) with 200 versus 400 cGy of total body irradiation (TBI) in patients with acute leukemia undergoing first allogeneic blood or marrow Transplantation (BMT). The primary objective is to compare the rates of graft-versus-host disease-free and relapse-free survival (GRFS) between patients in the two cohorts.
Primary Outcome
Number of patients without grade III-IV acute GVHD, chronic GVHD requiring systemic immune suppression, disease relapse or progression, or death by any cause from time of transplant until end of study
Conditions Studied
Interventions
- RADIATION 200 cGy or 400 cGy total body irradiation (TBI)
Study Locations (1)
Maryland
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-03-27 |
| Est. Completion | 2030-09-30 |
| Phase | NA |
What NCT06803745 shows while recruiting
NCT06803745 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 459-participant average among 37 other Acute Leukemia trials with a reported enrollment target (65% lower).
The record links to 2 conditions, with Acute Leukemia appearing as the primary indexed condition, and to 1 intervention - of which 200 cGy or 400 cGy total body irradiation (TBI) is the first listed.
NCT06803745 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06803745 about?
NCT06803745 is a clinical study titled "Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)". This is a randomized phase II trial of standard-of-care reduced-intensity conditioning (RIC) with 200 versus 400 cGy of total body irradiation (TBI) in patients with acute leukemia undergoing first allogeneic blood or marrow Transplantation (BMT). The primary objective is to compare the rates of gra...
What is the current status of trial NCT06803745?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-03-27. Estimated completion is 2030-09-30.
What conditions does trial NCT06803745 study?
This clinical trial studies the following conditions: Acute Leukemia, Acute Lymphoblastic Lymphoma.
What interventions are being tested in trial NCT06803745?
The interventions under investigation include: 200 cGy or 400 cGy total body irradiation (TBI) (RADIATION).
Who is sponsoring clinical trial NCT06803745?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06803745 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06803745's enrollment target sits among peer trials
160 14th of 37 higher than 24 of 37 other Acute Leukemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
RECRUITING · NA
-
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
RECRUITING · NA
-
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
RECRUITING · NA
-
Prevention of Hospital Acquired Deconditioning in Hospitalized Acute Leukemia Patients
ACTIVE NOT RECRUITING · NA
-
A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors
ACTIVE NOT RECRUITING · NA
-
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI